X0206 3 2019-10-02 0 0001781983 Aprea Therapeutics, Inc. APRE 0001789039 Abrahmsen Lars B. 535 BOYLSTON STREET BOSTON MA 02116 true SVP, Chief Scientific Officer Stock Option (right to buy) 0.92 2026-09-14 Common Stock 105587 D Stock Option (right to buy) 1.01 2027-11-24 Common Stock 56157 D Stock Option (right to buy) 3.19 2029-02-28 Common Stock 101083 D Twenty-five percent of these options vested on April 20, 2017, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions. Twenty-five percent of these options vested on November 24, 2018, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions. Twenty-five percent of these options vest on February 28, 2020, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions. Exhibit 24 - Power of Attorney /s/ Scott M. Coiante, attorney-in-fact 2019-10-02